Block, Siteadmin, SkipCaptcha, Upload, Automoderated users, delete, edit, move, nsTeam2RO, nsTeam2RW, nsTeam2_talkRO, nsTeam2_talkRW, protect, rollback, Administrators, template
293,594
edits
Changes
Jump to navigation
Jump to search
Line 1:
Line 1: − +
no edit summary
'''Remdesivir''' is an overpriced, sometimes harmful and mostly ineffective patented medication being promoted by [[liberal]]s to treat [[coronavirus]]. It is administered intravenously and thus requires a very costly 5-day stay in a hospital, in addition to thousands of dollars per patient charged by a pharmaceutical company for the medication itself.<ref>https://www.cbsnews.com/news/gilead-coronavirus-treatment-remdesivir-private-insurance-cost/</ref> Although remdesivir was heavily touted by [[liberal]]s, on Oct. 16 [[CNN]] admitted, "Big global study finds remdesivir doesn't help Covid-19 patients."<ref>https://www.cnn.com/2020/10/15/health/remdesivir-covid-who-trial-mortality/index.html</ref>
'''Remdesivir''' is an overpriced, sometimes harmful and mostly ineffective patented medication being promoted by [[liberal]]s to treat [[coronavirus]]. It is administered intravenously and thus requires a very costly 5-day stay in a hospital, in addition to thousands of dollars per patient charged by a pharmaceutical company for the medication itself.<ref>https://www.cbsnews.com/news/gilead-coronavirus-treatment-remdesivir-private-insurance-cost/</ref> Although remdesivir was heavily touted by [[liberal]]s, on Oct. 16 [[CNN]] admitted, "Big global study finds remdesivir doesn't help Covid-19 patients."<ref>https://www.cnn.com/2020/10/15/health/remdesivir-covid-who-trial-mortality/index.html</ref>
[[File:Fauci.PNG|right|225px|thumb|Anthony Fauci]]
As of November 19, 2020, "A [[World Health Organization]] panel is now recommending against the use of the antiviral remdesivir in hospitalized Covid-19 patients, saying there is no evidence that the drug — which U.S. regulators have approved for the treatment of the coronavirus — improves mortality."<ref>https://www.statnews.com/2020/11/19/who-recommends-against-remdesivir-covid-19/</ref>
As of November 19, 2020, "A [[World Health Organization]] panel is now recommending against the use of the antiviral remdesivir in hospitalized Covid-19 patients, saying there is no evidence that the drug — which U.S. regulators have approved for the treatment of the coronavirus — improves mortality."<ref>https://www.statnews.com/2020/11/19/who-recommends-against-remdesivir-covid-19/</ref>